Fentiazac

This classification denotes a cyclooxygenase inhibitor with the molecular formula C17H12ClNO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0YHF6E6NLS, chemically known as 5-thiazoleacetic acid, 4-(p-chlorophenyl)-2-phenyl- but generally known as fentiazac, which bears US NIH Compound Identifier 28871. European Medicines Agency schedules Fentiazac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07598MIG. The term FENTIAZAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules fentiazac in its Anatomical Therapeutic Chemical (ATC) Classification. FENTIAZAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fentiazac under HS 29341000 and SITC 51579. As of Q4 2014, FENTIAZAC remains the US FDA Preferred Term for this commodity. Fentiazac bears US NLM identifiers UMLS ID C0060201 and NCI Concept Code C81063. SMILES: CLC1CCC(C2NC(SC2CC(=O)O)C2CCCCC2)CC1.